Earlier in the year, SenseTime Medical triumphantly concluded a strategic funding round, securing over 500 million yuan. This achievement propelled its valuation to exceed 1 billion USD, thus earning it a spot among the esteemed unicorns. At present, SenseTime Medical is orchestrating what is set to be the largest funding round within the global medical world model sector. The Series A funding round has attracted joint investments from numerous well-known capital firms, with existing shareholders also opting to further augment their stakes. Since 2026, world models have captured considerable interest, with the medical field emerging as a pivotal arena for their application. Traditional medical AI technology pathways, however, have started to reveal their limitations. SenseTime Medical stands out with its prowess in the "world model platform." It has laid a solid technological foundation and developed a comprehensive product matrix, highlighted by a production platform capable of generating over 200 AI application models. Through its innovative "Agentic AI + Doctor Co-Creation" model, SenseTime Medical has established a distinctive product iteration system, substantially boosting operational efficiency. Currently, SenseTime Medical has established partnerships with over 500 leading hospitals. It is also collaborating with pharmaceutical and medical device companies on the industrial front to jointly drive the global expansion of medical AI. The founder of SenseTime Medical envisions that the medical world model architecture will be at the heart of the next-generation medical infrastructure. This funding round is strategically aimed at attracting more industry-synergistic partners to join forces in this transformative journey.